Viemed Healthcare (VMD) Competitors $7.10 +0.14 (+2.01%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$7.10 0.00 (0.00%) As of 08/8/2025 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VMD vs. PNTG, AVAH, AGL, CDNA, FLGT, FTRE, PSNL, AUNA, LFMD, and OMDAShould you be buying Viemed Healthcare stock or one of its competitors? The main competitors of Viemed Healthcare include The Pennant Group (PNTG), Aveanna Healthcare (AVAH), Agilon Health (AGL), CareDx (CDNA), Fulgent Genetics (FLGT), Fortrea (FTRE), Personalis (PSNL), Auna (AUNA), LifeMD (LFMD), and Omada Health (OMDA). These companies are all part of the "healthcare" industry. Viemed Healthcare vs. Its Competitors The Pennant Group Aveanna Healthcare Agilon Health CareDx Fulgent Genetics Fortrea Personalis Auna LifeMD Omada Health Viemed Healthcare (NASDAQ:VMD) and The Pennant Group (NASDAQ:PNTG) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, analyst recommendations and risk. Do analysts prefer VMD or PNTG? The Pennant Group has a consensus price target of $33.80, indicating a potential upside of 30.00%. Given The Pennant Group's stronger consensus rating and higher possible upside, analysts clearly believe The Pennant Group is more favorable than Viemed Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Viemed Healthcare 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00The Pennant Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60 Does the media refer more to VMD or PNTG? In the previous week, The Pennant Group had 4 more articles in the media than Viemed Healthcare. MarketBeat recorded 11 mentions for The Pennant Group and 7 mentions for Viemed Healthcare. The Pennant Group's average media sentiment score of 0.46 beat Viemed Healthcare's score of 0.38 indicating that The Pennant Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Viemed Healthcare 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral The Pennant Group 4 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more risk & volatility, VMD or PNTG? Viemed Healthcare has a beta of 1.33, meaning that its stock price is 33% more volatile than the S&P 500. Comparatively, The Pennant Group has a beta of 1.48, meaning that its stock price is 48% more volatile than the S&P 500. Do institutionals & insiders believe in VMD or PNTG? 74.2% of Viemed Healthcare shares are held by institutional investors. Comparatively, 85.9% of The Pennant Group shares are held by institutional investors. 20.0% of Viemed Healthcare shares are held by company insiders. Comparatively, 5.4% of The Pennant Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Is VMD or PNTG more profitable? Viemed Healthcare has a net margin of 5.80% compared to The Pennant Group's net margin of 3.36%. Viemed Healthcare's return on equity of 10.38% beat The Pennant Group's return on equity.Company Net Margins Return on Equity Return on Assets Viemed Healthcare5.80% 10.38% 7.88% The Pennant Group 3.36%9.85%4.04% Which has higher earnings and valuation, VMD or PNTG? The Pennant Group has higher revenue and earnings than Viemed Healthcare. Viemed Healthcare is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioViemed Healthcare$224.26M1.23$11.27M$0.3420.88The Pennant Group$695.24M1.29$22.56M$0.7634.21 SummaryThe Pennant Group beats Viemed Healthcare on 12 of the 16 factors compared between the two stocks. Get Viemed Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for VMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VMD vs. The Competition Export to ExcelMetricViemed HealthcareMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$269.95M$10.57B$5.44B$9.61BDividend YieldN/A2.01%4.61%4.14%P/E Ratio20.8819.8629.7524.84Price / Sales1.2321.90449.1298.65Price / Cash7.4021.7436.4258.36Price / Book1.952.858.185.64Net Income$11.27M$211.77M$3.26B$265.68M7 Day Performance19.73%3.65%6.88%4.95%1 Month Performance1.72%2.67%1.00%0.83%1 Year Performance-2.20%-9.41%28.85%22.18% Viemed Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VMDViemed Healthcare2.4963 of 5 stars$7.10+2.0%N/A-1.1%$269.95M$224.26M20.881,179News CoveragePositive NewsEarnings ReportHigh Trading VolumePNTGThe Pennant Group3.3881 of 5 stars$22.16+0.4%$33.80+52.5%-9.6%$760.73M$695.24M29.167,000News CoveragePositive NewsAnalyst UpgradeAVAHAveanna Healthcare0.7395 of 5 stars$3.82+2.1%$5.25+37.4%+35.5%$729.65M$2.02B191.0033,500Trending NewsAnalyst UpgradeAGLAgilon Health2.06 of 5 stars$1.82+6.8%$4.71+159.7%-84.4%$703.72M$6.06B-3.081,076Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap DownCDNACareDx4.0888 of 5 stars$12.60+3.1%$29.33+132.8%-56.3%$680.42M$333.79M10.96740Earnings ReportAnalyst ForecastFLGTFulgent Genetics3.7655 of 5 stars$18.36-0.9%$23.00+25.3%-17.0%$564.12M$283.47M-11.061,313Earnings ReportAnalyst UpgradeFTREFortrea4.0999 of 5 stars$6.42+17.6%$13.73+113.8%-73.3%$494.13M$2.70B-0.7315,500Earnings ReportAnalyst ForecastPSNLPersonalis3.8201 of 5 stars$5.57+3.3%$7.67+37.6%+31.5%$476.07M$84.61M-4.32400News CoverageEarnings ReportAnalyst ForecastAnalyst RevisionAUNAAuna3.0984 of 5 stars$6.25+1.2%$10.70+71.3%-17.2%$456.66M$1.17B10.7714,842LFMDLifeMD2.3094 of 5 stars$12.35+24.2%$13.86+12.2%+30.7%$451.75M$212.45M-36.32230News CoverageAnalyst ForecastAnalyst RevisionHigh Trading VolumeOMDAOmada HealthN/A$17.84+2.6%$23.86+33.7%N/A$447.54MN/A0.00849News CoverageEarnings ReportAnalyst Forecast Related Companies and Tools Related Companies PNTG Competitors AVAH Competitors AGL Competitors CDNA Competitors FLGT Competitors FTRE Competitors PSNL Competitors AUNA Competitors LFMD Competitors OMDA Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VMD) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredFOUR TRILLION DOLLARS!Nvidia just became the first company in history to hit a $4 trillion valuation—surpassing Apple and Microsoft....Porter & Company | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viemed Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viemed Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VMD Stock Alerts